The TNA Solutions IPO is a closed SME Bookbuilding offer (Fresh capital only) that opened on 30 September 2026. The TNA Solutions IPO closed on 6 October 2026, with an issue price of ₹70 per share. The TNA Solutions IPO has a face value of ₹10 and a lot size of 2,000 shares. The TNA Solutions IPO size aggregates up to ₹38 crore, listing on BSE SME on 9 October 2026. The TNA Solutions IPO allotment was scheduled for 7 October 2026.
On the financial front, the TNA Solutions IPO reported revenue of ₹110 for 31 Mar 2026, compared with ₹84 for 31 Mar 2025. The TNA Solutions IPO PAT was ₹10 against ₹7. The TNA Solutions IPO EBITDA stood at ₹13 with a 12.12% margin. The TNA Solutions IPO net worth as of 31 Mar 2026 was ₹36.
Always verify The TNA Solutions IPO details and GMP data with the official offer document before investing in the TNA Solutions IPO.
Financial Summary
Amount in ₹ Lakhs
Metric
31 Mar 2026
31 Mar 2025
31 Mar 2024
Total Assets
94
57
24
Revenue
110
84
36
PAT
10
7
3
EBITDA
13
10
5
Net Worth
36
23
5
Reserves
33
20
3
Total Borrowing
46
26
11
TNA Solutions IPO Financials FAQs
Revenue of TNA Solutions (Amount in ₹ Lakhs) — 31 Mar 2026: 110; 31 Mar 2025: 84; 31 Mar 2024: 36. Profit after tax (PAT) — 31 Mar 2026: 10; 31 Mar 2025: 7; 31 Mar 2024: 3.
EBITDA of TNA Solutions (Amount in ₹ Lakhs) — 31 Mar 2026: 13; 31 Mar 2025: 10; 31 Mar 2024: 5. The EBITDA margin is 12.12%.
Total assets — 31 Mar 2026: 94; 31 Mar 2025: 57; 31 Mar 2024: 24. Net worth — 31 Mar 2026: 36; 31 Mar 2025: 23; 31 Mar 2024: 5. Reserves & surplus — 31 Mar 2026: 33; 31 Mar 2025: 20; 31 Mar 2024: 3. (Amount in ₹ Lakhs)
Total borrowing of TNA Solutions (Amount in ₹ Lakhs) — 31 Mar 2026: 46; 31 Mar 2025: 26; 31 Mar 2024: 11. Debt-to-equity ratio: 1.29.
The financials shown for TNA Solutions IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.